Hexun Biosciences Co., LTD. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.

1. Notable

   Mesenchymal Stem Cells, HeXell-2020, · Stable Coronary Artery…Mesenchymal Stem Cells, HeXell-2020, · Stable Coronary Artery Disease

   Primary completion pushed from Dec 31, 2027 to Dec 31, 2028

   Also in this update: Recruitment opened; Study completion pushed from Jul 31, 2028 to Jul 31, 2029

   Hexun Biosciences Co., LTD.·Phase 1/2· NCT07137104· Registry history of NCT07137104 on ClinicalTrials.gov (opens the registry)

   Sep 29, 2026

2. Notable

   Mesenchymal Stem Cells, HeXell-2020, · Mild to Moderate Frailty…Mesenchymal Stem Cells, HeXell-2020, · Mild to Moderate Frailty Syndrome

   Primary completion pushed from Jan 31, 2028 to Dec 31, 2028

   Also in this update: Study completion pushed from Jul 31, 2028 to Jul 31, 2029

   Hexun Biosciences Co., LTD.·Phase 1· NCT07144072· Registry history of NCT07144072 on ClinicalTrials.gov (opens the registry)

   Sep 25, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.